Kalorama

Companion diagnostics are revolutionizing pharmaceutical development and treatment, particularly in oncology. By identifying patients with specific biomarkers or disease-specific therapeutic targets, companion diagnostics significantly improve clinical success rates and patient outcomes. They also reduce costs by pinpointing the patient population most likely to benefit from a therapy and excluding those for whom the therapy would…

Outsourcing drug discovery represents the initial phase of the drug development process. By outsourcing segments of their drug discovery programs, pharmaceutical and biotechnology companies have discovered a cost-effective strategy that enhances hit-to-lead conversion and early identification of ineffective compounds. Outsourcing accelerates the drug discovery process, transforming the industry from low-end research services to high-value, sophisticated…

What is the size of the cell and gene therapy market? According to Cell Therapy and Gene Therapy Markets, 2020 from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3.9 billion, with most of the market focused on the treatment of cancer. This exciting period in the…

Description:

The past few years have seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market, and many more are in development. In recent years, diagnostics companies, in collaboration with AI companies, have begun implementing increasingly sophisticated machine learning…

The wound care market is a technologically advanced sector focused on improving wound care therapies for patients and healthcare providers. Kalorama Information’s report, Worldwide Wound Care Market Summary, explores the market opportunities in this critical field, with a particular focus on biotechnology applications such as advanced biodressings and negative pressure wound systems. Worldwide Wound Care…

Non-alcoholic steatohepatitis (NASH) is a serious liver disease characterized by inflammation and liver cell damage, which can lead to cirrhosis. Despite the absence of approved medications specifically for NASH, there are nearly 80 drug candidates in development. Kalorama Information’s report, NASH Drug Pipeline and Market Overview, provides an in-depth analysis of these drug candidates, including…

CAR-T Cell Therapy Market Review provides an insightful examination of CAR-T therapy, a revolutionary form of immunotherapy harnessing the body’s T cells to target and eradicate cancer cells. This report delves into the technology behind CAR-T, its application in treating diseases like acute lymphoblastic leukemia, DLBCL B-cell lymphomas, and multiple myeloma.

Key Objectives and Questions…

This report delves into the burgeoning Exome Sequencing Market, offering a comprehensive exploration of its trends, technologies, and market dynamics. Covering the period from 2019 to 2024, it provides valuable insights into the global landscape of exome sequencing, with a particular focus on regional analyses.

Key components of this report include:

• An introduction to…

Blockchain Technologies in Healthcare explores the transformative potential of blockchain technology in the healthcare sector. This report offers a comprehensive overview of blockchain applications in various healthcare domains, including genomics, electronic health records, personal health records, drug supply chain security, clinical trial management, medical device tracking, and food safety diagnostics.

 

Key Features:

• Overview…

This report provides an insightful update on the global in vitro diagnostics (IVD) market, analyzing various factors shaping its current landscape. Covering a span from 2019 to 2024, key topics include:

• Market Developments in Key Regions: North America, EU15/Western Europe, Eastern Europe, Japan, and China
• Examination of Genetic Testing Trends
• Insights into New Point-of-Care…

HbA1c testing has become a critical component in the detection and monitoring of diabetes, leading to a highly competitive and rapidly growing market within the in vitro diagnostics (IVD) industry. With increasing global expenditures on both professional and self-testing HbA1c assays, the market is flourishing. Over a dozen companies are actively producing analyzers, reagents, workstations,…

Healthcare faces complex challenges, from staff reductions to increased service demands and funding cuts. In response, the industry is increasingly turning to advanced solutions that artificial intelligence (AI) offers. Kalorama Information’s report, The Market for Artificial Intelligence (AI) in Healthcare, 2019-2024, quantifies the current and future opportunities for AI in healthcare, already an almost two-billion-dollar…